[1]Department of Urology,Nottingham City Hospital,Nottingham University Hospitals NHS Trust,Nottingham,NG7 2UH,United Kingom;
[2]the John van Geest Cancer Research Centre,Nottingham Trent University,Nottingham,NG11 8NS,United Kingom;
[2]the John van Geest Cancer Research Centre,Nottingham Trent University,Nottingham,NG11 8NS,United Kingom;
[2]the John van Geest Cancer Research Centre,Nottingham Trent University,Nottingham,NG11 8NS,United Kingom;
[3]Department of Cellular Pathology,Queen’s Medical Centre,Nottingham University Hospitals NHS Trust,Nottingham NG7 2UH,United Kingom;
Prostate cancer; Molecular classification; Biomarker; Breast cancer; Prognostic;